title: Drugs for malaria: something old, something new, something borrowed.
abstract: Malaria was estimated to cause 800,000 deaths and 225 million cases worldwide in 2010. Worryingly, the first-line treatment currently relies on a single drug class called artemisinins, and there are signs that the parasite is becoming resistant to these drugs. The good news is that new technology has given us new approaches to drug discovery. New drugs generated this way are probably 10-15 years away from the clinic. Other antimalarials that may offer hope include those rehabilitated after not being used for some time, those that act as inhibitors of resistance mechanisms, those that limit infection while allowing protective immunity to develop, and those which are drugs borrowed from other disease treatments. All of these offer new hope of turning the tables on malaria. In parallel with the effort to develop vaccines that interrupt malaria transmission, drugs that target the parasite during transmission to the mosquito or during its pre-erythrocytic development in the liver, may allow us to terminate the parasite's spread.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Hobbs
authors.forename: Patrick
authors.initials: P
authors.lastname: Duffy
references.citation: Antimicrob Agents Chemother. 2008 Jul;52(7):2435-41
references.pmid: 18443130
references.citation: Antimicrob Agents Chemother. 2008 Jul;52(7):2653-6
references.pmid: 18443126
references.citation: N Engl J Med. 2009 Jul 30;361(5):468-77
references.pmid: 19641203
references.citation: Am J Trop Med Hyg. 2007 Oct;77(4):627-32
references.pmid: 17978061
references.citation: Lancet. 2011 May 21;377(9779):1770-6
references.pmid: 21514658
references.citation: ChemMedChem. 2007 Jul;2(7):944-86
references.pmid: 17530725
references.citation: Antimicrob Agents Chemother. 2010 Jul;54(7):2886-92
references.pmid: 20421395
references.citation: Nat Med. 2003 Jan;9(1):93-6
references.pmid: 12483205
references.citation: PLoS Med. 2011 Jan 25;8(1):e1000402
references.pmid: 21311580
references.citation: PLoS One. 2011 Mar 31;6(3):e18162
references.pmid: 21483865
references.citation: Nature. 2008 Oct 9;455(7214):757-63
references.pmid: 18843361
references.citation: Antimicrob Agents Chemother. 2005 Jul;49(7):2983-5
references.pmid: 15980379
references.citation: Trends Parasitol. 2010 Mar;26(3):145-51
references.pmid: 20133198
references.citation: Nat Rev Drug Discov. 2009 Nov;8(11):879-91
references.pmid: 19834482
references.citation: Science. 2010 Sep 3;329(5996):1153-4
references.pmid: 20813940
references.citation: AIDS. 2007 Mar 30;21(6):763-5
references.pmid: 17413699
references.citation: Curr Top Med Chem. 2011;11(10):1226-54
references.pmid: 21401508
references.citation: Drugs. 2000 Apr;59(4):719-43
references.pmid: 10804031
references.citation: Curr Infect Dis Rep. 2007 Jan;9(1):47-54
references.pmid: 17254504
references.citation: J Infect Dis. 2006 Apr 15;193(8):1151-9
references.pmid: 16544256
references.citation: PLoS Pathog. 2011 Apr;7(4):e1002015
references.pmid: 21490952
references.citation: Exp Parasitol. 2009 Oct;123(2):122-7
references.pmid: 19538959
references.citation: Science. 2011 Aug 5;333(6043):724-9
references.pmid: 21817045
references.citation: Lancet. 2010 Apr 24;375(9724):1413-4
references.pmid: 20417841
references.citation: J Infect Dis. 2010 Sep 1;202(5):801-8
references.pmid: 20662717
references.citation: Am J Trop Med Hyg. 2006 May;74(5):708-15
references.pmid: 16687667
references.citation: Nature. 2010 May 20;465(7296):305-10
references.pmid: 20485427
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4400-5
references.pmid: 21300861
references.citation: Antimicrob Agents Chemother. 2007 Feb;51(2):716-23
references.pmid: 17116676
references.citation: Antimicrob Agents Chemother. 2007 Feb;51(2):759-62
references.pmid: 17088482
references.citation: N Engl J Med. 2005 Apr 14;352(15):1565-77
references.pmid: 15829537
references.citation: Trends Parasitol. 2011 Jul;27(7):306-14
references.pmid: 21435951
references.citation: Science. 2006 Dec 8;314(5805):1603-6
references.pmid: 17158329
references.citation: Curr Opin Infect Dis. 2007 Dec;20(6):598-604
references.pmid: 17975410
references.citation: Mol Biochem Parasitol. 2011 Jun;177(2):160-3
references.pmid: 21316401
references.citation: Nature. 2002 Oct 3;419(6906):498-511
references.pmid: 12368864
references.citation: Lancet Infect Dis. 2010 Jan;10(1):51-9
references.pmid: 20129149
references.citation: PLoS One. 2010 Dec 09;5(12):e14275
references.pmid: 21151554
references.citation: Parasitol Res. 2011 Dec;109(6):1519-24
references.pmid: 21537980
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9059-64
references.pmid: 18579783
references.citation: Antimicrob Agents Chemother. 2006 Feb;50(2):639-48
references.pmid: 16436721
references.citation: Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13137-41
references.pmid: 12198181
references.citation: Emerg Infect Dis. 2005 Sep;11(9):1410-9
references.pmid: 16229771
references.citation: Clin Infect Dis. 2004 Nov 1;39(9):1336-45
references.pmid: 15494911
references.citation: PLoS Negl Trop Dis. 2010 Aug 03;4(8):e774
references.pmid: 20689816
references.citation: N Engl J Med. 2009 Jul 30;361(5):455-67
references.pmid: 19641202
references.citation: J Infect Dis. 2009 Jan 1;199(1):134-41
references.pmid: 19032102
references.citation: Malar J. 2011 Feb 02;10:23
references.pmid: 21288352
references.citation: Malar J. 2008 Jul 22;7:134
references.pmid: 18647387
references.citation: N Engl J Med. 2006 Nov 9;355(19):1959-66
references.pmid: 17093247
references.citation: Lancet Infect Dis. 2010 Oct;10(10):673-81
references.pmid: 20832366
references.citation: J Infect Dis. 2011 May 15;203(10):1445-53
references.pmid: 21502082
references.citation: Science. 2010 Sep 3;329(5996):1175-80
references.pmid: 20813948
references.citation: Infect Disord Drug Targets. 2010 Jun;10(3):226-39
references.pmid: 20334617
references.citation: Curr Opin Infect Dis. 2007 Feb;20(1):3-10
references.pmid: 17197875
references.citation: Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):739-49
references.pmid: 10365399
references.citation: Nature. 2010 May 20;465(7296):311-5
references.pmid: 20485428
references.citation: Expert Rev Anti Infect Ther. 2011 Apr;9(4):393-6
references.pmid: 21504396
references.citation: Lancet. 1996 Jun 15;347(9016):1654-8
references.pmid: 8642959
references.citation: Discov Med. 2010 May;9(48):389-98
references.pmid: 20515606
references.citation: J Clin Invest. 2008 Apr;118(4):1266-76
references.pmid: 18382739
references.citation: Malar J. 2008 Dec 16;7:255
references.pmid: 19087267
references.citation: J Infect Dis. 2006 Jan 1;193(1):1-3
references.pmid: 16323123
references.citation: Clin Infect Dis. 2008 Sep 15;47(6):804-11
references.pmid: 18699744
references.citation: Acta Trop. 2006 Feb;97(2):212-8
references.pmid: 16329985